secwatch / observer
8-K filed May 7, 2024, 7:59 PM ET ticker QDEL CIK 0001906324
leadership confidence high sentiment neutral materiality 0.65

QuidelOrtho appoints Brian J. Blaser as CEO effective May 6, 2024

QuidelOrtho Corp

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian J. Blaser

President and Chief Executive Officer
QDEL · QuidelOrtho Corp
Effective
2024-05-06
Filed
May 7, 2024, 7:59 PM ET
The Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) has appointed Brian J. Blaser to serve as the Company’s President and Chief Executive Officer, effective as of May 6, 2024 (the “Effective Date”).
Role change (interim)

Robert J. Bujarski

Interim President
QDEL · QuidelOrtho Corp
Effective
2024-05-06
Successor
Brian J. Blaser
Filed
May 7, 2024, 7:59 PM ET
each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.
Appointed

Brian J. Blaser

director
QDEL · QuidelOrtho Corp
Effective
2024-05-15
Filed
May 7, 2024, 7:59 PM ET
In addition, effective as of May 15, 2024, the Board expanded its size from ten to eleven directors and appointed Mr. Blaser to serve as a director until the Company’s 2025 Annual Meeting of Stockholders.
Role change (interim)

Michael S. Iskra

Interim Chief Executive Officer
QDEL · QuidelOrtho Corp
Effective
2024-05-06
Successor
Brian J. Blaser
Filed
May 7, 2024, 7:59 PM ET
each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. Blaser was appointed as President and Chief Executive Officer at QuidelOrtho Corp.

Action
appointed
Role
President and Chief Executive Officer
Exact text from the filing
The Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) has appointed Brian J. Blaser to serve as the Company’s President and Chief Executive Officer, effective as of May 6, 2024 (the “Effective Date”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert J. Bujarski changed role as Interim President at QuidelOrtho Corp.

Action
stepped down
Role
Interim President
Exact text from the filing
each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. Blaser was appointed as director at QuidelOrtho Corp.

Action
appointed
Role
director
Exact text from the filing
In addition, effective as of May 15, 2024, the Board expanded its size from ten to eleven directors and appointed Mr. Blaser to serve as a director until the Company’s 2025 Annual Meeting of Stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael S. Iskra changed role as Interim Chief Executive Officer at QuidelOrtho Corp.

Action
stepped down
Role
Interim Chief Executive Officer
Exact text from the filing
each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.
View on SEC.gov

QuidelOrtho Corp filing history →

Source: SEC EDGAR
accession 0001906324-24-000025
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.